Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Myopia (nearsighted) is the most common cause of impaired vision in people under age 40 while presbyopia is the normal loss of near focusing ability that occurs with age. The symptoms of myopia and presbyopia include squinting, eye strain, and headaches. The conditions can be corrected or treated with eyeglasses, contact lenses or refractive surgery. Moreover, eye drops containing medication are also emerging treatment for myopia and presbyopia. Increasing geriatric population is one of the major factors driving growth of the market, as presbyopia is an age-related visual impairment.   

The global myopia and presbyopia treatment market is estimated to be valued at US$ 17.9 Billion in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027).

Figure 1. Global Myopia and Presbyopia Treatment Market Value (US$ Bn) & Y-o-Y Growth Analysis, (2016-2027)

Myopia and Presbyopia Treatment  | Coherent Market Insights

Continuous product developments by leading players and research institutes is expected to drive growth of the myopia and presbyopia treatment market

The development and launching of innovative products such as eyeglasses, lenses, and other eye wears is expected to drive the market growth. Moreover, most of the players are also engaged in research and development activities, in order to develop medications for treating   myopia and presbyopia treatment. For instance, on April 24, 2019, Sydnexis, Inc. initiated a phase 3 clinical trial study to evaluate the safety and effectiveness of SYD-101 sterile topical ophthalmic solution (atropine sulfate) in children with myopia. The study is estimated to be completed in July 2024. Also, on June 3, 2019, Eyenovia Inc. initiated phase 3 clinical trial study to evaluate the progression of myopia in participants using microdosed atropine 0.01%, atropine 0.1% or placebo ophthalmic solution. The study is estimated to be completed in May 2024.

Thus, such increasing number of lead candidates in late phase (phase 3), which may have potential to gain FDA approval for further use, is expected to drive growth of the global myopia and presbyopia treatment market during the forecast period.

The launch of new products by major players such as Alcon, Ophtec BV, BVI, BAUSCH + LOMB Incorporated, and others is a major factor that drives growth of the market. For instance, in March 2020, Alcon launched AcrySof IQ Vivity, a first-of-its-kind intraocular lens (IOL) (presbyopia-correcting IOLs (PC-IOLs)). In September 2018, OPHTEC BV launched a new IOL concept for the correction of presbyopia with an optic using the patented Continuous Transitional Focus (CTF) technology.

request-sample

Myopia and Presbyopia Treatment Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 17.9 Bn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 8.1% 2027 Value Projection: US$ 31.0 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Disease Type: Myopia, Presbyopia.
  • By Treatment Type: Prescription Lenses, Contact Lenses, Surgery, Medication, Others.
Companies covered:

ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International.

Growth Drivers:
  • Increasing number of product launches
  • Increasing prevalence of myopia and presbyopia among geriatric population
  • Presence of major players in key regions
Restraints & Challenges:
  • Product Recall

Global Myopia and Presbyopia Treatment Market: Impact of Coronavirus (Covid-19) Pandemic

Covid-19 outbreak has negatively impacted growth of the myopia and presbyopia treatment market, as small and medium ophthalmology practices have been completely shut down due to the lockdown in key regions and only large ophthalmology practices are remained open, which are dealing with emergency cases. This has reduced the number of patient visits to ophthalmology clinics and in turn, decreased demand for contact lenses, prescription lenses, and other eye wears.

Global Myopia and Presbyopia Treatment Market- Regional Analysis

On the basis of region, the global myopia and presbyopia treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to exhibit high growth potential over the forecast period in the myopia and presbyopia treatment market, owing to increasing prevalence of myopia and presbyopia among the regional population. For instance, according to American Academy of Ophthalmology, in 2016, an estimated 9.6 Billion adults in the U.S. were highly myopic or severely nearsighted. Among these, around 820,000 have a degenerative form of the disease and over 41,000 suffer from a complication called myopic choroidal.

Moreover, presence of leading players such as Carl Zeiss, Visioneering Technologies, Inc., and Alcon in Europe region is expected to drive growth of the Europe myopia and presbyopia treatment market, as these players are continuously focusing on product development and launches. For instance, in February 2019, Visioneering Technologies, Inc. launched NaturalVue Brand Contact Lenses for myopia progression control & presbyopia in the U.K.

Figure 2: Global Myopia and Presbyopia Treatment Market Share (%) in Terms of Value, By Region (2020 & 2027)

Myopia and Presbyopia Treatment  | Coherent Market Insights

Global Myopia and Presbyopia Treatment Market- Competitive Landscape

Key players operating in the global myopia and presbyopia treatment market include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International.

Myopia and presbyopia are terms that represent dysfunctionality in the eyes. In case of myopia, there is difficulty in viewing distant objects and in case of presbyopia, natural lens loses its flexibility to move its focus between near and far objects. Presbyopia occurs in people aged between 40-50 years. Myopia and presbyopia can be treated by surgeries and medication. Also, these conditions can be corrected with glasses or contact lenses. The prevalence of myopia and presbyopia are rising across the world.

Market Dynamics

Frequents approvals for novel treatment options such as lenses and others is expected to drive market growth. For instance, in October 2018, Carl Zeiss Meditec AG (ZEISS) received the U.S. FDA approval for its ReLEx SMILE, to expand the myopia treatment for the patients with astigmatism. Moreover, in September 2018, STAAR Surgical Company received the U.S. FDA approval (PMA Supplement) for Visian Toric ICL for the correction of myopia with astigmatism. Thus, such increasing approvals have provided opportunity for the manufacturers to introduce novel products in the market, which is contributing to growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the myopia and presbyopia treatment market, market size (US$ Billion) and compound annual growth rate (CAGR (%)) for the forecast period, 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global myopia and presbyopia treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, end user upgrades, market expansion, and marketing tactics
  • The global myopia and presbyopia treatment market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for myopia and presbyopia treatment market, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the myopia and presbyopia treatment market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Myopia And Presbyopia Treatment Market, By Disease Type :
    • Myopia
    • Presbyopia
  • Global Myopia And Presbyopia Treatment Market, By Treatment Type
    • Prescription Lenses
    • Contact Lenses
    • Surgery
    • Medication
    • Others
  • Global Myopia And Presbyopia Treatment Market, By Region:
    • North America
      • By Disease Type:
        • Myopia
        • Presbyopia
      • By Treatment Type
        • Prescription Lenses
        • Contact Lenses
        • Surgery
        • Medication
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Disease Type:
        • Myopia
        • Presbyopia
      • By Treatment Type
        • Prescription Lenses
        • Contact Lenses
        • Surgery
        • Medication
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Disease Type:
        • Myopia
        • Presbyopia
      • By Treatment Type
        • Prescription Lenses
        • Contact Lenses
        • Surgery
        • Medication
        • Others
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Disease Type:
        • Myopia
        • Presbyopia
      • By Treatment Type
        • Prescription Lenses
        • Contact Lenses
        • Surgery
        • Medication
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Disease Type:
        • Myopia
        • Presbyopia
      • By Treatment Type
        • Prescription Lenses
        • Contact Lenses
        • Surgery
        • Medication
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Disease Type:
        • Myopia
        • Presbyopia
      • By Treatment Type
        • Prescription Lenses
        • Contact Lenses
        • Surgery
        • Medication
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • ALCON Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Bausch Health Companies Inc.
    • EssilorLuxottica (Essilor Ltd.)
    • Johnson & Johnson Vision
    • NIDEK CO. LTD.
    • Topcon Corporation
    • Zeimer Ophthalmic Systems AG
    • ZEISS International

“*” marked represents similar segmentation in other categories in the respective section

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Disease Type
      • Market Snippet, By Treatment Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Impact Analysis
    • Technological Evolution
    • PEST Analysis
    • Microscope Comparison
    • Porters Analysis
    • COVID-19 Impact Analysis
  4. Global Myopia And Presbyopia Treatment Market, Impact of COVID-19 Pandemic
    • Pre-Covid Impact
    • Post-Covid Impact
    • Demand and Supply Impact Analysis
  5. Global Myopia And Presbyopia Treatment Market, By Disease Type, 2020–2027 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Myopia
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
        • Presbyopia
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
  6. Global Myopia And Presbyopia Treatment Market, By Treatment Type, 2020–2027 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Prescription Lenses
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
        • Contact Lenses
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
        • Surgery
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
        • Medication
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
  7. Global Myopia And Presbyopia Treatment Market, By Region, 2020–2027 (US$ Bn)
    • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017–2027
      • North America
        • Market Size and Forecast, By Disease Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
          • U.S.
          • Canada
          • Europe
        • Market Size and Forecast, By Disease Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
          • U.K.
          • Germany
          • Italy
          • France
          • Spain
          • Russia
          • Rest of Europe
          • Asia Pacific
        • Market Size and Forecast, By Disease Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
          • China
          • India
          • Japan
          • ASEAN
          • Australia
          • South Korea
          • Rest of Asia Pacific
          • Latin America
        • Market Size and Forecast, By Disease Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Bn
        • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
          • Brazil
          • Argentina
          • Mexico
          • Rest of Latin America
          • Africa
        • Market Size and Forecast, By Disease Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Bn)
          • Central Africa
          • South Africa
          • North Africa
          • Middle East
        • Market Size and Forecast, By Disease Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Treatment Type, 2016–2027 (US$ Bn)
        • Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
          • GCC
          • Israel
          • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • ALCON Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bausch Health Companies Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • EssilorLuxottica (Essilor Ltd.)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson & Johnson Vision
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • NIDEK CO. LTD.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Topcon Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Zeimer Ophthalmic Systems AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ZEISS International
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Myopia and Presbyopia Treatment Market - Global forecast to 2027”.

Frequently Asked Questions

The global myopia and presbyopia treatment market size is estimated to be valued at US$ 17.9 Billion in 2020 and is expected to exhibit a CAGR of 8.1% between 2020 and 2027.
Myopia segment is estimated to account for major market share in 2020, owing to increasing prevalence of myopia that results in rising demand for contact and prescription lenses.
Prescription lenses segment is estimated to account for major market share in 2020, owing to increasing product launches of prescription lenses.
Major factors driving growth of the global myopia and presbyopia treatment market include increasing product launches.
North America myopia and presbyopia treatment market is expected to generate largest revenue share during the forecast period.
Some of the key players operating in the myopia and presbyopia treatment market include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner